A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.

Moore, Kathleen N

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer. [electronic resource] - Future oncology (London, England) Jan 2018 - 123-136 p. digital

Publication Type: Journal Article; Review

1744-8301

10.2217/fon-2017-0379 doi


Antibodies, Monoclonal, Humanized--therapeutic use
Drug Resistance, Neoplasm--genetics
Female
Folate Receptor 1--antagonists & inhibitors
Humans
Immunoconjugates--immunology
Maytansine--analogs & derivatives
Ovarian Neoplasms--drug therapy
Platinum--adverse effects